Global Vaccine Adjuvant Market Forecasted to Reach USD 6.93 Billion by 2028
01 avr. 2024 18h06 HE
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvant Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class, Type,...
Dyadic Reports 2023 Full Year Results and Recent Company Progress
28 mars 2024 16h00 HE
|
Dyadic International, Inc.
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...
[Latest] Global Cancer Immunotherapy Market Size/Share Worth USD 314.4 Billion by 2032 at a 7.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
28 mars 2024 15h30 HE
|
Custom Market Insights
Austin, TX, USA, March 29, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Immunotherapy Market Size, Trends and Insights By Type of Immunotherapy...
Dyadic Announces Change in Board and Management Leadership Roles
28 mars 2024 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030: A $1.28 Trillion Opportunity, Driven by the Rising Adoption of AI-based Tools for Drug Discovery
27 mars 2024 08h34 HE
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product...
Dyadic to Attend Industry Events in April
27 mars 2024 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Vaccines Market Research Report 2024: Focus on Commercialized and Developmental Vaccines
21 mars 2024 07h40 HE
|
Research and Markets
Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "The World Market for Vaccines, 2024" report has been added to ResearchAndMarkets.com's offering. The World Market for Vaccines, 2024 offers the...
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
19 mars 2024 07h30 HE
|
Evaxion Biotech
The proprietary AI-Immunology™ platform brings the potential for a new era in vaccine discovery, design and development using advanced AI and machine learning technologiesAI-Immunology™ outcompetes...
Monkeypox Vaccine and Treatment Market Research Report 2024: Global Industry Analysis, Trends, Market Size, and Forecasts 2022-2030
18 mars 2024 05h57 HE
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Monkeypox Vaccine and Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030" report has been added to ...
MEDI8897 (Nirsevimab) Market Landscape 2024-2032: Mechanism, Dosage, Regulatory Milestones, Global R&D, Patents, Sales Forecast, Emerging Therapies
15 mars 2024 09h01 HE
|
Research and Markets
Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "MEDI8897 Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report offers...